Oncology nurses not adhering to safe handling guidelines of antineoplastic agents
the ONA take:
According to a new study funded by the National Institute for Occupational Safety and Health (NIOSH) and published online in the Journal of Occupational and Environmental Hygiene, researchers have found that healthcare workers do not always follow recommended safe handling practices for the administration of antineoplastic drugs in healthcare settings.
Of 2,100 oncology nurses and other healthcare personnel, 80% do not wear two pairs of chemotherapy gloves and 15% do not even wear a single pair during the administration of antineoplastic agents to patients. In addition, 42% do not always wear a nonabsorbent gown with closed front and tight-fitting cuffs. Of those surveyed, 12% report taking home potentially contaminated clothing and 4% report skin contact with an antineoplastic agent.
The researchers suggest that better communication surrounding the risks of not following the best practice recommendations put forth by authoritative safe handling guidelines. Healthcare workers and oncology nurses should be fully aware of the hazards associated with not following these guidelines and the precautionary measures that can be used to minimize exposure to antineoplastic agents.
Healthcare workers do not always follow recommended safe handling practices for antineoplastic drugs.
A new National Institute for Occupational Safety and Health (NIOSH) study, published online in the Journal of Occupational and Environmental Hygiene, found that recommended safe handling practices for workers who administer antineoplastic drugs in healthcare settings are not always followed. Results are derived from the 2011 Health and Safety Practices Survey of Healthcare Workers, the largest federally-sponsored survey of healthcare workers in the U.S., which addresses safety and health practices relative to use of hazardous chemicals.This paper presents findings on current administrative and engineering control practices, personal protective equipment (PPE), and barriers to using recommended PPE during administration of antineoplastic drugs by nearly 2,100 oncology nurses and other healthcare personnel who completed a module addressing antineoplastic drug administration.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|